Bluejay Diagnostics, Inc.
NASDAQBluejay Diagnostics enters May having shed the short position built up during one of the most compressed stretches the stock has seen in over a year. The defining move of the past six weeks was a dramatic unwinding of short interest, not a build. Short interest peaked at roughly 6.6% of the free float in late March, with shares-short sitting above 55,000. By April 30, that had…
BJDX short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for BJDX below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for BJDX are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 May 2026
Bluejay Diagnostics enters May having shed the short position built up during one of the most compressed stretches the stock has seen in over a year. The defining move of the past six weeks was a dramatic unwinding of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BJDX — free to start on ORTEX.
Sign up for free →Open BJDX on ORTEX